How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?

We suggested de-escalation would be possible for cervical cancer like human papillomavirus (HPV)-related oropharyngeal cancer. However, the classification was based on tumor shrinkage that can be obtained after half of the treatment was finished. Our other article found adverse factors which can be obtained prior to treatment, and they might classify patients earlier.

Automated summary

The study suggested the possibility of de-escalation for cervical cancer, similar to HPV-related oropharyngeal cancer. However, the classification was based on tumor shrinkage after half of the treatment, while another article found adverse factors that could be obtained prior to treatment, allowing for earlier patient classification.